Pure Extracts Logo.jpg
Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion
December 15, 2020 00:05 ET | Pure Extracts Technologies Corp.
--Special Access Programme Review Considered a Milestone Event Toward Mainstream Acceptance VANCOUVER, British Columbia, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE:...
logo.jpg
CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings
December 14, 2020 08:07 ET | Cybin Inc.
--Newly acquired novel psychedelic molecules diversify Cybin’s development portfolio, providing access to multiple future indications-- --Adelia brings a range of technologies related to novel...
Cybin LOGO.png
New Study Finds Psychedelic Treatments More Effective than Typical Antidepressant Medications
November 13, 2020 08:30 ET | Cybin Inc.
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Cybin Inc. (NEO: CYBN) announces the availability of a broadcast titled, “On the Trail of Better Therapeutics for Depression.” To...
Cybin LOGO.png
New Therapeutic Protocols Targeting Debilitating Disorders on the Horizon
November 11, 2020 08:30 ET | Cybin Inc.
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands...
AlliendCorp_logo.png
Allied Expands Pharmaceutical Pipeline By Filing US Provisional Patent for Psilocybin Based Therapeutics
October 20, 2020 08:55 ET | Allied Corp.
KELOWNA, British Columbia, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Allied Corp. (“Allied”) (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid...
Cybin LOGO.png
Psychedelics Experiencing Renaissance, Offer Tremendous Treatment Potential
October 16, 2020 08:30 ET | Cybin Corp.
NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio -- Cybin Corp. announces the availability of a broadcast titled, “Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics.” ...
Cybin LOGO.png
Psychedelic Drugs Offering New Hope for Treatment of Debilitating Disorders
October 15, 2020 08:30 ET | Cybin Corp.
NEW YORK, Oct. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — Cybin Corp. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ brands in the...
Cybin LOGO.png
Cybin Corp. CEO Discusses Ongoing Efforts to Develop One of the First Commercially Approved Psychedelic Medications for Mental Health
September 15, 2020 08:30 ET | Cybin Corp.
NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio — Cybin Corp. today announces that its chief executive officer, Doug Drysdale, is featured in an exclusive audio interview with...
ehave-logo.png
Ehave, Inc. to Participate in Psychedelic Capital Virtual Event September 3, 2020
September 03, 2020 08:45 ET | Ehave
Psychedelic Capital produces a monthly virtual investor conference with the top performing companies in the psychedelic space. Investors can sign up at...
Mindset Logo with text.png
Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds
August 31, 2020 07:00 ET | Mindset Pharma Inc.
TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Mindset Pharma ("Mindset"), a leading drug discovery and development business focused on next-generation psychedelic medicines to treat neuropsychiatric...